ratutrelvir

·Code: TRX01

ratutrelvir: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
TRAWS PHARMA, INC. (ONTX)Phase 2

Clinical Trials (1)

A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate Safety and Efficacy of Ratutrelvir and Standard of Care in Non-hospitalized Symptomatic Adult Participants With Mild to Moderate COVID-19

NCT07157007·Phase 2·ONTX
Recruiting

Frequently asked questions

Who is developing ratutrelvir?

ratutrelvir is being developed by TRAWS PHARMA, INC..

How many clinical trials involve ratutrelvir?

BioSniper tracks 1 clinical trial involving ratutrelvir.

Get deeper analysis on ratutrelvir

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    ratutrelvir — Drug Pipeline, Trials & FDA Status | BioSniper